Prognostic Value of the Modified Glasgow Prognostic Score in Patients with Metastatic Renal Cell Carcinoma Receiving Nivolumab as Second-Line Therapy: A Multicentre Retrospective Cohort Study - Sedat Biter; Ertuğrul Bayram; Tolga Köşeci; Mehmet Cihan İçli and Ahmet Melih Arslan and Faruk Recep Özalp and Nadiye Sever and Ahmet Ünsal and Nargiz Majidova Altuntaş and Mustafa Seyyar and Gülhan Dinç and Mahmut Büyükşimşek and Mehmet Türker and Şendağ Yaslıkaya and Mehmet Mutlu Kıdı and Yasemin Aydınalp Camadan and Umut Kefeli and Mehmet Uzun and Hasan Çağrı Yıldırım and Hüseyin Salih Semiz and Mustafa Erman and İsmail Oğuz Kara (Medicina, 2026)